Results 121 to 130 of about 302,854 (293)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages

open access: yesiMeta
Dysbiosis of the gut microbiota has been implicated in hypertension, and drug–host–microbiome interactions have drawn considerable attention. However, the influence of angiotensin receptor blocker (ARB)‐shaped gut microbiota on the host is not fully ...
Jing Li   +8 more
doaj   +1 more source

Family History of Hypertension Influences Left Ventricular Diastolic Function During Chronic Antihypertensive Therapy [PDF]

open access: bronze, 2007
Andrea Grandi   +8 more
openalex   +1 more source

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

open access: yesESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra   +25 more
wiley   +1 more source

Resistant arterial hypertension in a patient with adrenal incidentaloma multiple steno-obstructive vascular lesions and antiphospholipid syndrome [PDF]

open access: yes, 2015
Resistant hypertension is defined as above of blood pressure (≤ 140/90 mmHg) despite therapy with three or more antihypertensive drugs of different classes at maximum tolerable doses with one bling a diuretic.
CONCISTRE, ANTONIO   +8 more
core  

Advancing cardio‐obstetric care through digital health technologies: A narrative review

open access: yesESC Heart Failure, EarlyView.
Telehealth has enhanced prenatal and post‐partum care by improving access, continuity, and equity, particularly for high‐risk and underserved populations, without compromising maternal or fetal outcomes. Wearable and digital health technologies (e.g., electrocardiogram sensors, remote BP monitoring, mobile interventions) show strong potential to ...
Toluwalase Awoyemi   +11 more
wiley   +1 more source

Amlodipine and atenolol poisoning - A race against time for physicians

open access: yesCurrent Medicine Research and Practice
A fixed-dose combination (FDC) of amlodipine and atenolol is a commonly used antihypertensive drug that is often found in households. However, when taken in high doses, this medication can lead to serious and potentially fatal complications such as ...
Aadhar Mathur   +3 more
doaj   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

open access: yesESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek   +3 more
wiley   +1 more source

Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF‐ImmunoCS

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We have previously shown that patients who develop heart‐reactive antibodies (HRAs) de novo after a heart failure (HF) hospitalization are at increased risk of adverse outcomes, lending weight to the hypothesis that B cells may play a pivotal role in HF progression.
Niklas Beyersdorf   +19 more
wiley   +1 more source

Antihypertensives in dementia: Good or bad for the brain? [PDF]

open access: hybrid, 2022
Lucy Beishon   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy